Envista Holdings Corp
- NYSE
- NVST
- CIK
- 1757073
- Industry
- Dental Equipment & Supplies
- Based in
- Brea, California
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
- SEC filer category
- Large accelerated filer
- Employer ID (EIN)
- 83-2206728
About
AI summary. This paragraph was summarized by AI from the company’s annual report. It may contain mistakes: check it against the source. How it was written
Envista is a family of more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, that develops, manufactures, and markets products used by dental professionals to diagnose, treat, and prevent dental conditions. It operates through two segments. Specialty Products & Technologies comprises Dental Implant Solutions, offering implant systems, regenerative solutions, prosthetics, and treatment-planning software, and Orthodontic Solutions, offering brackets, wires, Spark clear aligners, and lab products, sold mainly directly to oral surgeons, general dentists, orthodontists, and other specialists. Equipment & Consumables comprises Diagnostic Solutions, including imaging systems, intraoral scanners, and DTX Studio software, and Consumables Solutions, including restorative, endodontic, and infection prevention products, sold mainly through channel partners. Formed in 2018 and separated from Danaher Corporation in 2019, Envista serves customers in over 130 countries.
Source: the Business section of the company’s 10-K filed Feb 12, 2026.
Key figures
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | $2.72B | $2.51B | $2.57B | $2.57B | $2.51B |
| Operating income | $216.1M | −$1.04B | $31.5M | $319.2M | $306.2M |
| Net income | $47.0M | −$1.12B | −$100.2M | $243.1M | $340.5M |
| Diluted EPS | $0.28 | −$6.50 | −$0.60 | $1.37 | $1.92 |
| Cash from operations | $275.7M | $336.5M | $275.7M | $182.7M | $361.6M |
| Total assets | $5.68B | $5.35B | $6.61B | $6.59B | $6.57B |
| Shareholders’ equity | $3.11B | $2.93B | $4.17B | $4.21B | $4.06B |
From the company’s annual reports to the SEC. Each year links to its report.
Financials 29
- 10-Q Quarterly Report for period ending Oct 2, 2026
- 10-Q Quarterly Report for period ending Jul 3, 2026
- 10-Q Quarterly Report for period ending Apr 3, 2026
- 10-K Annual Report for period ending Dec 31, 2025
- 10-Q Quarterly Report for period ending Sep 26, 2025
- 10-Q Quarterly Report for period ending Jun 27, 2025
- 10-Q Quarterly Report for period ending Mar 28, 2025
- 10-K Annual Report for period ending Dec 31, 2024
- 10-Q Quarterly Report for period ending Sep 27, 2024
- 10-Q Quarterly Report for period ending Jun 28, 2024
News 82
- 8-K Financial results; Regulation FD disclosure
- 8-K Regulation FD disclosure
- 8-K Regulation FD disclosure
- 8-K Director or officer change; Other events
- 8-K Financial results; Regulation FD disclosure
- 8-K Director or officer change
- 8-K Shareholder vote results
- 8-K Financial results; Regulation FD disclosure
- 8-K Financial results; Regulation FD disclosure
- 8-K Financial results; Regulation FD disclosure
Ownership 375
- SCHEDULE 13G Major shareholder report (passive investor)
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 4 Change in insider ownership
- 144 Notice of proposed sale of restricted stock
- 4 Change in insider ownership
- 4 Change in insider ownership
Prospectus 28
- 424B2 Prospectus filed pursuant to Rule 424(b)(2)
- FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
- 424B2 Prospectus filed pursuant to Rule 424(b)(2)
- S-3ASR Automatic shelf registration statement of securities of well-known seasoned issuers
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 POS Post-effective amendment to a S-8 registration statement
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
- S-8 POS Post-effective amendment to a S-8 registration statement
Proxies 16
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEF 14A Definitive proxy statements
- PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
- DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
Other 31
- SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
- ARS Annual report to security holders
- 11-K Annual report of employee stock purchase, savings and similar plans
- SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
- ARS Annual report to security holders
- 11-K Annual report of employee stock purchase, savings and similar plans
- SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
- ARS Annual report to security holders
- 11-K Annual report of employee stock purchase, savings and similar plans
- SD Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)